Post by
nozzpack on Aug 26, 2020 10:39am
Other Considerations of Fair Value
The Ebitda multiple is another way to value DR.
I provide data for the last 3 years along with net debt ( cash less LT debt )
Year Ebitda EV EV/Ebitda net debt
2017 $94.6 m $551 m 5.8 $9 m
2018 $99.0 m $518 m 5.2 $25 m
2019 $96.2 m $419 m 4.4 $35 m
2020( H1 x 2 ) $86.2m $125 m 1.5 $-11 m
DR has the best balance sheet in its recent history and with the sale of low margin assets, has very robust operating margins.
The average EV to Ebitda for recent years is 4.8.
DR is currently trading at just 1.5 times, which suggests a 3 fold increase from current levels by exit 2020................ approx $13 per share
Comment by
nozzpack on Aug 27, 2020 5:08am
The average EV to Ebitda multiple for the US Hospital Healthcare sector is 9.37 https://pages.stern.nyu.edu/~adamodar/New_Home_Page/datafile/vebitda.html
Comment by
nozzpack on Aug 27, 2020 1:37pm
Using peer EV to Ebitda multiple for the US ( 9.37 ), DR would be valued above $20 per share. It is in fact not unreasonable, as DR now have no net debt and pays a very nice dividend..